FMP

FMP

Enter

ACLX - Arcellx, Inc.

photo-url-https://financialmodelingprep.com/image-stock/ACLX.png

Arcellx, Inc.

ACLX

NASDAQ

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent SparX proteins targeting BCMA to treat r/r MM; ACLX-002 and ACLX-003 for treating r/r acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS); and other AML/MDS product candidates, as well as solid tumor programs. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Gaithersburg, Maryland.

85.97 USD

-1.28 (-1.49%)

About

ceo

Mr. Rami Elghandour

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent SparX proteins targeting BCMA to treat r/r MM; ACLX-002 and ACLX-003 for treating r/r acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS); and other AML/MDS product candidates, as well as solid tumor programs. The company was formerly known...

CIK

0001786205

ISIN

US03940C1009

CUSIP

03940C100

Address

25 West Watkins Mill Road

Phone

240 327 0603

Country

US

Employee

130

IPO Date

Feb 4, 2022

ACLX Financial Summary

CIK

0001786205

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

03940C100

ISIN

US03940C1009

Country

US

Price

85.97

Beta

0.25

Volume Avg.

480.47k

Market Cap

4.62B

Shares

-

52-Week

34.225-97.54

DCF

68.86

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-82.66

P/B

-

Website

https://arcellx.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest ACLX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep